U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.2939T>A (p.Ile980Lys) AND Cystic fibrosis

Germline classification:
Conflicting interpretations of pathogenicity (4 submissions)
Last evaluated:
Nov 10, 2023
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000577032.12

Allele description [Variation Report for NM_000492.4(CFTR):c.2939T>A (p.Ile980Lys)]

NM_000492.4(CFTR):c.2939T>A (p.Ile980Lys)

Gene:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.2939T>A (p.Ile980Lys)
HGVS:
  • NC_000007.14:g.117606704T>A
  • NG_016465.4:g.145921T>A
  • NM_000492.4:c.2939T>AMANE SELECT
  • NP_000483.3:p.Ile980Lys
  • NP_000483.3:p.Ile980Lys
  • LRG_663t1:c.2939T>A
  • LRG_663:g.145921T>A
  • LRG_663p1:p.Ile980Lys
  • NC_000007.13:g.117246758T>A
  • NM_000492.3:c.2939T>A
Protein change:
I980K
Links:
dbSNP: rs397508463
NCBI 1000 Genomes Browser:
rs397508463
Molecular consequence:
  • NM_000492.4:c.2939T>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Cystic fibrosis (CF)
Synonyms:
Mucoviscidosis
Identifiers:
MONDO: MONDO:0009061; MedGen: C0010674; Orphanet: 586; OMIM: 219700

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000679364ClinVar Staff, National Center for Biotechnology Information (NCBI)
no classification provided
not providedgermlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

SCV000796476Counsyl
criteria provided, single submitter

(Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018))
Uncertain significance
(Dec 14, 2017)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link,

SCV001583667Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 10, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

SCV002752446Ambry Genetics
criteria provided, single submitter

(Ambry General Variant Classification Scheme_2022)
Likely pathogenic
(Jul 1, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedliterature only
not providedgermlineunknown1not providednot provided1not providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?

Dorfman R, Nalpathamkalam T, Taylor C, Gonska T, Keenan K, Yuan XW, Corey M, Tsui LC, Zielenski J, Durie P.

Clin Genet. 2010 May;77(5):464-73. doi: 10.1111/j.1399-0004.2009.01351.x. Epub 2009 Jan 6.

PubMed [citation]
PMID:
20059485

Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients.

Hubert D, Bienvenu T, Desmazes-Dufeu N, Fajac I, Lacronique J, Matran R, Kaplan JC, Dusser DJ.

Eur Respir J. 1996 Nov;9(11):2207-14.

PubMed [citation]
PMID:
8947061
See all PubMed Citations (6)

Details of each submission

From ClinVar Staff, National Center for Biotechnology Information (NCBI), SCV000679364.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Counsyl, SCV000796476.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV001583667.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces isoleucine, which is neutral and non-polar, with lysine, which is basic and polar, at codon 980 of the CFTR protein (p.Ile980Lys). This variant is present in population databases (rs397508463, gnomAD 0.003%). This missense change has been observed in individual(s) with congenital absence of the vas deferens and/or cystic fibrosis (PMID: 8829643, 8947061, 11101688, 21520337). ClinVar contains an entry for this variant (Variation ID: 53604). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CFTR protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Ambry Genetics, SCV002752446.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

The p.I980K variant (also known as c.2939T>A), located in coding exon 18 of the CFTR gene, results from a T to A substitution at nucleotide position 2939. The isoleucine at codon 980 is replaced by lysine, an amino acid with dissimilar properties. This variant was reported in two individuals, who also had another pathogenic mutation, with congenital bilateral absence of the vas deferens (CBAVD). One individual also had an elevated sweat chloride concentration and presented with chronic sinusitis, nasal polyposis and pancreatic sufficiency (Bienvenu et al. Hum Mutat. 1996;7:182). In another study, this variant was seen in two patients in a cohort of 305 with CBAVD, of which one individual also had p.R117H and the other individual had c.3605delA, however further clinical information was not provided (Steiner et al. Hum Mutat. 2011;32:912-20). In a group of 110 patients who were diagnosed with cystic fibrosis by two abnormal sweat chloride levels and/or two CFTR mutations, one was reported with this variant (Hubert et al. Eur. Respir. J. 1996;9(11):2207-14). This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6495 samples (12990 alleles) with coverage at this position. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown1not providednot provided1not providednot providednot provided

Last Updated: Mar 16, 2024